CIK 0001426800 · Non-accelerated filer<br>Smaller reporting company
ASSEMBLY BIOSCIENCES, INC.
Sign in to watch- Ticker
- ASMB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (833) 409-4583
- Business address
- TWO TOWER PLACE, 7TH FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- VENTRUS BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $237,648
- in 4 filings
Net −$237,648. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-05 | Houghton Michael Director | Grant or award · Stock Option (right to buy) | +3,500 | 3,500 | ||
| 2025-06-05 | Mahony Susan Director | Grant or award · Stock Option (right to buy) | +3,500 | 3,500 | ||
| 2025-06-05 | McHutchison John G Director | Grant or award · Stock Option (right to buy) | +3,500 | 3,500 | ||
| 2025-06-05 | Johnson-Pratt Lisa Director | Grant or award · Stock Option (right to buy) | +3,500 | 3,500 | ||
| 2025-06-05 | RINGO WILLIAM R Director | Grant or award · Stock Option (right to buy) | +3,500 | 3,500 | ||
| 2025-06-05 | ALTIG ANTHONY E Director | Grant or award · Stock Option (right to buy) | +3,500 | 3,500 | ||
| 2025-06-05 | Consylman Gina Director | Grant or award · Stock Option (right to buy) | +3,500 | 3,500 | ||
| 2025-03-31 | McHutchison John G Director | Sale | −757 | $9.85 | $7K | 18,347 |
| 2025-03-31 | Bjorkquist Jeanette M Principal Accounting Officer | Sale | −180 | $9.85 | $2K | 4,617 |
| 2025-03-31 | Okazaki Jason A CEO and President | Sale | −355 | $9.85 | $3K | 14,757 |
| 2025-03-31 | White Nicole S Chief Manufacturing Officer | Sale | −197 | $9.85 | $2K | 11,674 |
| 2025-03-29 | Delaney William E IV Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +25,500 | 25,500 | ||
| 2025-03-29 | Bjorkquist Jeanette M Principal Accounting Officer | Grant or award | +1,655 | 4,797 | ||
| 2025-03-29 | Bjorkquist Jeanette M Principal Accounting Officer | Grant or award · Stock Option (right to buy) | +1,900 | 1,900 | ||
| 2025-03-29 | Okazaki Jason A CEO and President | Grant or award · Stock Option (right to buy) | +71,100 | 71,100 | ||
| 2025-03-29 | White Nicole S Chief Manufacturing Officer | Grant or award · Stock Option (right to buy) | +20,400 | 20,400 | ||
| 2025-03-29 | Gaggar Anuj Chief Medical Officer | Grant or award · Stock Option (right to buy) | +24,200 | 24,200 | ||
| 2024-12-30 | Houghton Michael Director | Purchase | +3,202 | $15.61 | $50K | 3,202 |
| 2024-12-19 | GILEAD SCIENCES, INC. 10% owner | Purchase | +940,499 | $21.37 | $20.1M | 2,209,471 |
| 2024-11-25 | Schornstein Alexander 10% owner | Purchase | +2,976 | $15.00 | $45K | 723,113 |
Page 3 of 15 · 297 trades